News Focus
News Focus
Followers 3
Posts 582
Boards Moderated 0
Alias Born 01/19/2012

Re: gi197845 post# 8302

Saturday, 04/29/2017 10:19:17 PM

Saturday, April 29, 2017 10:19:17 PM

Post# of 20617
Nice prediction from Yahoo board (SoCalDreamer72) : Hello everyone. With all the talk and speculation I figured I would take a stab at predicting INNV's
future pps. Instead of guessing, I looked at other Pharma companies and compared their numbers.
Yes, they are profitable, so will INNV be soon.
.
Celg $124 pps 774,000,000 shares MC 95.6 bill
Yearly rev. 11.229 billion

Pfizer. $33.88 pps. 5.9 billion shares MC 202b. Yearly revenue. 52.8 billion

Gsk $40.9 pps. 420,912,000 shares MC101.6 b
Yearly rev 27.8 billion

CELG revenue is 11.5% of market cap
Pfizers revenue is 26% of market cap
GSK. Revenue is 27% of market cap

This is a small sample, but I will toss CELG out as an outlier for the first number. This means that the average percentage of rev to market cap is 26.5%.

If INNV follows this same model then it will have 75 mill in revenues as stated earlier on this board. If that is 26.5% of market cap as per model then market cap should be 283 million. Dividing 283 million by os pps would be $2.28. That is figured by dividing market cap $283 million by os 124.8 million (per innv website.)

If using CELG as a model it would be $652 million mc and pps of $5.25.

I feel we have good times ahead. p.s. Its better then listen cry from Shawn .............

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today